Related Experiment Video
Updated: May 6, 2026

Optimization, Design and Avoiding Pitfalls in Manual Multiplex Fluorescent Immunohistochemistry
Published on: July 26, 2019
An optimized immunohistochemistry technique improves NMO-IgG detection: study comparison with cell-based assays
Romana Höftberger1, Lidia Sabater, Romain Marignier
1Service of Neurology, Hospital Clínic, Universitat de Barcelona and Institut d´Investigació Biomèdica August Pi i Sunyer (IDIBAPS), Barcelona, Spain ; Institute of Neurology, Medical University of Vienna, Vienna, Austria.
Insights
An optimized immunohistochemistry assay shows comparable sensitivity and specificity to cell-based assays for detecting neuromyelitis optica (NMO)-IgG/aquaporin-4-antibody. This finding offers a valuable alternative tool for NMO diagnosis.
Area of Science:
- Neurology
- Immunology
- Diagnostic Assays
Background:
- Cell-based assays (CBA) have improved detection of neuromyelitis optica (NMO)-IgG/aquaporin-4-antibody.
- Classical tissue-based assays have limitations in sensitivity.
Purpose of the Study:
- To compare the sensitivity and specificity of an optimized immunohistochemistry (IHC-o) assay.
- To evaluate IHC-o against in-house (CBA-ih) and commercial (CBA-c) cell-based assays for NMO-IgG/aquaporin-4-antibody detection.
Main Methods:
- Evaluated coded serum from 103 patients with definite NMO and 122 controls.
- Utilized IHC-o with a protocol for cell surface antigens.
- Employed CBA-ih with live cells expressing aquaporin-4-M23-isoform and CBA-c.
Main Results:
- IHC-o sensitivity was 74.8%, comparable to CBA-ih (75.7%) and CBA-c (73.8%).
- All three assays demonstrated 100% specificity.
- High interassay concordance was observed, with 100 of 103 samples showing agreement.
Conclusions:
- Optimized immunohistochemistry is a sensitive and specific method for NMO-IgG/aquaporin-4-antibody detection.
- IHC-o serves as a valuable addition to existing diagnostic tools for NMO.
Abstract:
Cell-based assays (CBA) have increased the sensitivity of the neuromyelitis optica (NMO)-IgG/aquaporin-4-antibody detection compared to classical tissue-based indirect assays. We describe the sensitivity of an optimized immunohistochemistry (IHC-o) to detect NMO-IgG/aquaporin-4-antibody in comparison with that of two CBA: an in-house (CBA-ih) and a commercial (CBA-c) assay (Euroimmun, Germany). Coded serum from 103 patients with definite NMO and 122 inflammatory controls were studied by IHC-o, CBA-ih, and CBA-c. IHC-o used the same protocol described to detect antibodies against cell surface antigens. CBA-ih used live cells transfected with the aquaporin-4-M23-isoform. The sensitivity of the IHC-o was 74.8% (95% confidence interval [CI] 65-83) and was similar to that of the CBA-ih 75.7% (95% CI 66-84) and the CBA-c 73.8% (95% CI 64-82). The specificity of the three assays was 100% (95% CI 97-100). Interassay concordance was high, 100 of 103 samples were coincident in all techniques. The optimized immunohistochemistry proves to be as sensitive and specific as the cell-based assays. This assay extends the available tools for NMO-IgG/aquaporin-4-antibody detection.
More Related Videos
Related Concept Videos
Immunocytochemistry and Immunohistochemistry
These...
Immunogold Electron Microscopy

